Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM

ConclusionsIn a randomized clinical trial in patients with HFrEF, men and women achieved similar doses of candesartan. Primary event rates and treatment-related discontinuation due to adverse events were also similar between men and women.

Source: ESC Heart Failure - April 6, 2024 Category: Cardiology Authors: Hailun Qin, Pooja Dewan, Bernadet T. Santema, Jozine M. ter Maaten, Karl Swedberg, John J. V. McMurray, Adriaan A. Voors Tags: Original Article Source Type: research